# Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria

> **NCT07470762** · PHASE1,PHASE2 · RECRUITING · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

- **DRUG:** HS-10542
- **DRUG:** HS-10542
- **DRUG:** HS-10542

## Key facts

- **NCT ID:** NCT07470762
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-14
- **Primary completion:** 2027-05-30
- **Final completion:** 2029-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470762, "Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07470762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*